Cargando…

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin

The quantitative relationship between iodine and glucose metabolism in metastases from differentiated thyroid cancer (DTC) remains unknown. Aim of the prospective study was to establish the value of (18)F-FDG PET/CT in predicting (131)I-avidity of metastases from DTC before the first radioiodine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Min, Cheng, Lingxiao, Jin, Yuchen, Ruan, Maomei, Sheng, Shiwei, Chen, Libo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847528/ https://www.ncbi.nlm.nih.gov/pubmed/29531251 http://dx.doi.org/10.1038/s41598-018-22656-4

Ejemplares similares

(99m)Tc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from (131)I therapy: A prospective observational study
por: Liu, Min, et al.
Publicado: (2017)

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin
por: Boktor, Raef R., et al.
Publicado: (2022)

Increased (18)F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report
por: Ruan, Maomei, et al.
Publicado: (2016)

Value of (18)F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Levels
por: Li, Hongyan, et al.
Publicado: (2021)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
por: RUAN, MAOMEI, et al.
Publicado: (2013)

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022)

Transient (18)FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)

A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
por: Cheng, Lingxiao, et al.
Publicado: (2017)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
por: Soydal, Çiğdem, et al.
Publicado: (2015)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
por: Byun, Byung Hyun, et al.
Publicado: (2013)

(18)F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
por: Gajendra, Smeeta, et al.
Publicado: (2016)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time
por: Sher, Avigaëlle, et al.
Publicado: (2016)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

Disseminated Multi-system Sarcoidosis Mimicking Metastases on (18)F-FDG PET/CT
por: Makis, William, et al.
Publicado: (2018)

Texture Analysis of (18)F-FDG PET/CT for Differential Diagnosis Spinal Metastases
por: Fan, Xin, et al.
Publicado: (2021)

Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on (18)F-FDG PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

FDG PET Predicts the Effects of (131)I and Prognosis for Patients with Bone Metastases from Differentiated Thyroid Carcinoma
por: Wang, Danyang, et al.
Publicado: (2020)

Value of Dedicated Head and Neck (18)F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative (131)I Whole-body Scan
por: Son, Mai Hong, et al.
Publicado: (2016)

Comparing the diagnostic efficacy of [(18)F]FDG PET/CT and [(18)F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
por: Xia, Longjie, et al.
Publicado: (2023)

Adrenal schwannoma can be FDG-Avid on PET/CT: case report and review of historic institutional pathology
por: Fackelmayer, Oliver J., et al.
Publicado: (2023)

Accuracy of [(18)F]FDG PET/MRI for the Detection of Liver Metastases
por: Beiderwellen, Karsten, et al.
Publicado: (2015)

(11)C-Choline-Avid but (18)F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
por: Kitajima, Kazuhiro, et al.
Publicado: (2016)

18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma
por: Gómez, Francisco Javier García, et al.
Publicado: (2015)

Rectal Carcinoma Metastases to Multiple Skeletal Muscles-Role of F-18 FDG PET/CT
por: Prabhu, Meghana, et al.
Publicado: (2017)

Comparison of MRI and 18F-FDG PET/CT in the Liver Metastases of Gastrointestinal and Pancreaticobiliary Tumors
por: Tahtabasi, Mehmet, et al.
Publicado: (2021)

An Uncommon Presentation of Leptomeningeal Metastases in Breast Carcinoma Detected by F-18 FDG PET/CT
por: Surya, Gavini, et al.
Publicado: (2022)

Role of (18)F-FDG PET/CT for detection of recurrence and metastases in renal cell carcinoma—are we underusing PET/CT?
por: Pereira, Melvika, et al.
Publicado: (2022)

FDG-avid antrum-pylorus ulcer, adjacent lymph node, and abdominal wall nodule mimicking gastric cancer with metastases
por: Ruan, Dan, et al.
Publicado: (2022)

Malignancy Risk in (18)F-FDG-Avid Thyroid Incidentalomas: Controversies and Limitations
por: Bukhari, Khulood, et al.
Publicado: (2021)

Multiple Subcutaneous (18)F-FDG-avid Granulomas Due to Enoxaparin Injection
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2022)

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity
por: Doherty, Leana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cprb6kctp000j6e82ssjun6l10